Skip to content
PIL Logo

Aimpart XL 2mg, 4mg & 8mg Prolonged-Release Tablets

Last Updated on eMC 29-Jan-2013 View document  | Zentiva Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29-Jan-2013 and displayed until Current

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects

Updated on 15-Oct-2012 and displayed until 29-Jan-2013

Reasons for adding or updating:

  • New PIL for new product

Company contact details


Company image

One Onslow Street, Guildford, Surrey, GU1 4YS


+44 (0) 1483 554831

Medical Information e-mail

+44 (0)1483 505 515

Medical Information Direct Line

+44 (0)845 372 7101

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

ropinirole hydrochloride

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue